Insider trading

Period: 120 months Stock: SHPH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
14 Jul 2026
HRT FINANCIAL LP 10% owner
Sold at will
$367.88K 82,116 at 4.48
100%
Sold half or more
13 Jul 2026
HRT FINANCIAL LP 10% owner
Sold at will
$4.82K 1,033 at 4.67
1.7%
Not planned
10 Jul 2026
HRT FINANCIAL LP 10% owner
Bought
$2.27K 731 at 3.11
1.2%
9 Jul 2026
HRT FINANCIAL LP 10% owner
Bought
$27.94K 8,266 at 3.38
15.8%
8 Jul 2026
HRT FINANCIAL LP 10% owner
Sold at will
$65.23K 18,531 at 3.52
26.2%
Not planned
7 Jul 2026
HRT FINANCIAL LP 10% owner
Sold at will
$35.23K 10,580 at 3.33
13.0%
Not planned
6 Jul 2026
HRT FINANCIAL LP 10% owner
Sold at will
$31.67K 9,022 at 3.51
10.0%
Not planned
2 Jul 2026
HRT FINANCIAL LP 10% owner
Bought
$27.79K 7,851 at 3.54
9.5%
1 Jul 2026
HRT FINANCIAL LP 10% owner
Bought
$13.06K 3,959 at 3.30
5.0%
30 Jun 2026
HRT FINANCIAL LP 10% owner
Bought
$21.82K 6,755 at 3.23
9.4%
29 Jun 2026
HRT FINANCIAL LP 10% owner
Bought
$88.88K 25,836 at 3.44
56.2%
First buy on file
13 Dec 2023
Jacobs Bette Director
Sold at will
$1.93K 4,157 at 0.46
13.3%
Not planned
13 Dec 2023
Brown Milton Director
Sold at will
$1.35K 2,921 at 0.46
0.3%
Not planned
29 Dec 2022
Dritschilo Anatoly CEO and Chairman
Sold, plan not stated
$13.44K 8,372 at 1.61
0.8%
29 Dec 2022
Jacobs Bette Director
Sold, plan not stated
$7.01K 4,366 at 1.61
12.3%
29 Dec 2022
Dritschilo Peter President and COO
Sold, plan not stated
$6.13K 3,820 at 1.61
36.8%
29 Dec 2022
Vander Hoek Michael Chief Financial Officer
Sold, plan not stated
$3.60K 2,243 at 1.61
36.8%
29 Dec 2022
Senanayake Chris Director
Sold at will
$2.61K 1,626 at 1.61
36.8%
Not planned
29 Dec 2022
Rich Tyvin Chief Medical Officer
Sold, plan not stated
$2.27K 1,414 at 1.61
36.8%
29 Dec 2022
Brown Milton Director
Sold, plan not stated
$1.60K 995 at 1.61
0.1%
29 Dec 2022
Adkins William Former Director
Sold, plan not stated
$1.60K 995 at 1.61
0.5%
29 Dec 2022
Sold, plan not stated
$1.60K 995 at 1.61
36.8%
29 Dec 2022
Jung Mira Chief Scientific Officer
Sold, plan not stated
$526.44 328 at 1.61
0.0%
Showing 1–23 of 23.